“The ROI calculator will have a significant impact across multiple areas. It will help tech developers create digital endpoints that meet economic and clinical needs, improving marketability. Researchers and institutions can use it to justify funding by demonstrating cost-effective, data-backed outcomes. It will be particularly valuable in Phase 2 and Phase 4 trials, where digital endpoints are widely used, providing more data. Healthcare payors and insurers may leverage it to assess long-term cost savings and treatment benefits, potentially influencing coverage decisions and reimbursement strategies. Additionally, it offers investors a clear financial rationale for funding companies developing or utilizing digital endpoints, attracting more capital to the space.”